abdominal sarcopenia. Among chronic aortic disease patients, thoracic and abdominal sarcopenia occurred in 37% and 35% (81% agreement). Sarcopenic patients were older, had lower body mass indices, and were more frequently male and white; comorbidities and procedural characteristics were similar between patient groups. Whereas abdominal sarcopenia did not predict mortality at any time point (Fig 1; 2-year mortality, 16% vs 15%; P ¼ .66), T12 sarcopenia was associated with substantially higher long-term mortality (Fig 2; 2-year mortality 23% vs 10%; P < .05). In contrast, among injured patients, thoracic sarcopenia was less frequent (15%), and was not associated with increased mortality (0% vs 15%; P ¼ .58).
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Rising Incidence of Femoral Pseudoaneurysm After Cardiac Catheterization Results in Significant Increases in Hospital Cost and Length of Stay
Justin W. Ady, Viktor Dombrovskiy, Saum A. Rahimi, Randy Shafritz. Rutgers University, New Brunswick, NJ Objectives: Femoral pseudoaneurysm (FPA) is the most common complication associated with percutaneous coronary interventions. The purpose of this study is to identify the risk factors associated with FPA after cardiac catheterization, and the impact of FPA on total hospital cost and duration of stay.
Methods 83 and OR, 1.64; 95% CI, 1.54-1.74, respectively). As expected, diagnostic procedures had the lowest rate of FPA (0.22%) compared with angioplasty (0.39%) or stent placement (0.33%; P < .0001). Surprisingly, patients with elective admission were 1.22 times as likely to have FPA (95% CI, 1.19-1.25) than those with nonelective hospitalization. Interestingly, patients in urban hospitals had the highest incidence of FPA (0.30% in urban teaching and 0.28% in urban nonteaching vs 0.20% in rural hospitals; P < .0001). Compared with the Northeast region, FPA incidence was greater in the West (OR, 1.12; 95% CI, 1.08-1.16) and highest in the Midwest and South regions (OR, 1.24; 95% CI, 1.20-1.28 for both). FPA resulted in a significant increase in duration of stay, from 3 days (IQR, 1-6 days) to 5 days (IQR, 3-9 days; P < .001), and resulted in a 30% increase in total cost of hospitalization, from $15,651 (IQR, $10,102-$24,967) to $22,347 (IQR, $15, 030) .
Conclusions: FPA after coronary procedures is a significant complication, resulting in unacceptable increases in both hospital duration of stay and total cost. With the incidence of FPA increasing, urgent attention and further root cause analysis is indicated to reduce this adverse trend in patient outcomes.
Author Disclosures: J. W. Ady: Nothing to disclose; V. Dombrovskiy: Nothing to disclose; S. A. Rahimi: Nothing to disclose; R. Shafritz: Nothing to disclose. Objectives: Smoking has been associated with poor postoperative outcomes across a wide range of vascular surgery procedures. The effect of quitting smoking before elective operations is unclear. Our goal was to assess the effect of timing of smoking cessation before open vascular surgery operations on perioperative outcomes Methods: The Vascular Quality Initiative was reviewed for all elective open abdominal aortic aneurysm (AAA) repairs and lower extremity bypass (LEB) in patients with a smoking history from 2010 to 2017. Three groups were identified those who had long-term smoking cessation (LTSC; quit smoking >8 weeks before operation), those who had shortterm smoking cessation (STSC; quit <8 weeks before operation), and those currently smoking (CS). Patient and case details were recorded.
PC080. The Effect of Smoking Cessation Timing
Multivariable analysis was used to analyze outcomes.
Results: We identified 5215 elective AAA (42.9% LTSC, 2.4% STSC, 54.7% CS) and 17,403 elective LEB (42.5% LTSC, 2.2% STSC, 54.8% CS). For AAA, STSC were more often younger, male, obese, have less chronic obstructive pulmonary disease (COPD) and diabetes, and more likely to be on a statin than CS (P < .05 for all). There was no difference in proximal aneurysm extent or approach. LTSC was associated with lower perioperative pulmonary complications (OR, 0.65; 95% CI, 0.53-0.79; P < .001), but this was not seen in STSC (OR, 0.52; 95% CI, 0.25-1.08; P < .081). There were no differences in cardiac, wound, leg or bowel ischemia, return to the operating room, or perioperative mortality based on smoking status. For LEB, STSC compared with CS were more often female, obese, nonCaucasian, diabetic, and had less coronary artery disease, congestive heart failure, chronic obstructive pulmonary disease, and more likely to be on an aspirin and a statin (P < .05 for all). LTSC and STSC were not associated with lower perioperative complications after LEB including pulmonary, stroke, wound, return to the operating room, or mortality. 
